» Articles » PMID: 39289621

The BCPM Method: Decoding Breast Cancer with Machine Learning

Overview
Journal BMC Med Imaging
Publisher Biomed Central
Specialty Radiology
Date 2024 Sep 17
PMID 39289621
Authors
Affiliations
Soon will be listed here.
Abstract

Breast cancer prediction and diagnosis are critical for timely and effective treatment, significantly impacting patient outcomes. Machine learning algorithms have become powerful tools for improving the prediction and diagnosis of breast cancer. The Breast Cancer Prediction and Diagnosis Model (BCPM), which utilises machine learning techniques to improve the precision and efficiency of breast cancer diagnosis and prediction, is presented in this paper. BCPM collects comprehensive and high-quality data from diverse sources, including electronic medical records, clinical trials, and public datasets. Through rigorous pre-processing, the data is cleaned, inconsistencies are addressed, and missing values are handled. Feature scaling techniques are applied to normalize the data, ensuring fair comparison and equal importance among different features. Furthermore, feature-selection algorithms are utilized to identify the most relevant features that contribute to breast cancer projection and diagnosis, optimizing the model's efficiency. The BCPM employs numerous machine learning methods, such as logistic regression, random forests, decision trees, support vector machines, and neural networks, to generate accurate models. Area under the curve (AUC), sensitivity, specificity, and accuracy are only some of the metrics used to assess a model's performance once it has been trained on a subset of data. The BCPM holds promise in improving breast cancer prediction and diagnosis, aiding in personalized treatment planning, and ultimately taming patient results. By leveraging machine learning algorithms, the BCPM contributes to ongoing efforts in combating breast cancer and saving lives.

References
1.
Park J, Chun M, Bae S, Woo J, Chon E, Kim H . Factors influencing psychological distress among breast cancer survivors using machine learning techniques. Sci Rep. 2024; 14(1):15052. PMC: 11219858. DOI: 10.1038/s41598-024-65132-y. View

2.
Jiang Z, Yang L, Jin L, Yi L, Bing P, Zhou J . Identification of novel cuproptosis-related lncRNA signatures to predict the prognosis and immune microenvironment of breast cancer patients. Front Oncol. 2022; 12:988680. PMC: 9531154. DOI: 10.3389/fonc.2022.988680. View

3.
He B, Dai C, Lang J, Bing P, Tian G, Wang B . A machine learning framework to trace tumor tissue-of-origin of 13 types of cancer based on DNA somatic mutation. Biochim Biophys Acta Mol Basis Dis. 2020; 1866(11):165916. DOI: 10.1016/j.bbadis.2020.165916. View

4.
He B, Lu Q, Lang J, Yu H, Peng C, Bing P . A New Method for CTC Images Recognition Based on Machine Learning. Front Bioeng Biotechnol. 2020; 8:897. PMC: 7423836. DOI: 10.3389/fbioe.2020.00897. View

5.
Lambertini M, Santoro L, Del Mastro L, Nguyen B, Livraghi L, Ugolini D . Reproductive behaviors and risk of developing breast cancer according to tumor subtype: A systematic review and meta-analysis of epidemiological studies. Cancer Treat Rev. 2016; 49:65-76. DOI: 10.1016/j.ctrv.2016.07.006. View